We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
-6.74%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$82.9B
AUM Growth
-$6.13B
Cap. Flow
+$2.62B
Cap. Flow %
3.16%
Top 10 Hldgs %
28.29%
Holding
7,503
New
382
Increased
2,612
Reduced
3,617
Closed
515

Sector Composition

Rank Sector Weight
1 Healthcare 4.85%
2 Technology 3.93%
3 Financials 3.3%
4 Energy 3.26%
5 Communication Services 2.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BR icon
3801
CALL
Broadridge
BR
$18.8B
$275K ﹤0.01%
+5,000
New +$269K
FLOT icon
3802
iShares Floating Rate Bond ETF
FLOT
$10.3B
$275K ﹤0.01%
5,499
-9,516
-63% -$481K
MAS icon
3803
CALL
Masco
MAS
$14.9B
$275K ﹤0.01%
11,000
-5,615
-34% -$144K
TFIN icon
3804
Triumph Financial Inc
TFIN
$1.81B
$275K ﹤0.01%
17,178
+14,394
+517% +$207K
TOUR
3805
Tuniu
TOUR
$55.9M
$275K ﹤0.01%
2,500
-1,250
-33% -$179K
LUMO
3806
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$275K ﹤0.01%
872
-6,914
-89% -$3.04M
ACHN
3807
PUT
DELISTED
Achillion Pharmaceuticals
ACHN
$275K ﹤0.01%
45,800
-46,400
-50% -$378K
GCI
3808
CALL
DELISTED
Gannett Co., Inc
GCI
$275K ﹤0.01%
19,650
+7,450
+61% +$97.5K
CHD icon
3809
CALL
Church & Dwight Co
CHD
$24.5B
$274K ﹤0.01%
6,600
-3,200
-33% -$137K
IRM icon
3810
CALL
Iron Mountain
IRM
$36.3B
$274K ﹤0.01%
8,850
-3,700
-29% -$110K
SCMP
3811
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$274K ﹤0.01%
14,438
+9,294
+181% +$213K
MWW
3812
CALL
DELISTED
Monster Worldwide Inc
MWW
$274K ﹤0.01%
45,600
-25,000
-35% -$170K
BC icon
3813
CALL
Brunswick
BC
$5.26B
$273K ﹤0.01%
5,800
+4,200
+263% +$214K
PHO icon
3814
Invesco Water Resources ETF
PHO
$2.08B
$273K ﹤0.01%
13,629
UYM icon
3815
PUT
ProShares Ultra Materials
UYM
$39.7M
$273K ﹤0.01%
36,400
-11,200
-24% -$108K
VMI icon
3816
PUT
Valmont Industries
VMI
$9.5B
$273K ﹤0.01%
2,900
RLYP
3817
DELISTED
RELYPSA INC COM
RLYP
$273K ﹤0.01%
15,151
+10,142
+202% +$279K
AWH
3818
DELISTED
Allied World Assurance Co Hld Lt
AWH
$273K ﹤0.01%
7,180
+5,490
+325% +$228K
CLDT
3819
Chatham Lodging
CLDT
$607M
$272K ﹤0.01%
12,859
-168,596
-93% -$4.18M
CROX icon
3820
PUT
Crocs
CROX
$6.43B
$272K ﹤0.01%
22,700
+12,600
+125% +$183K
DSX icon
3821
CALL
Diana Shipping
DSX
$312M
$272K ﹤0.01%
64,794
+16,306
+34% +$80.4K
MTZ icon
3822
CALL
MasTec
MTZ
$20.8B
$272K ﹤0.01%
18,100
+11,800
+187% +$206K
CC icon
3823
CALL
Chemours
CC
$2.27B
$271K ﹤0.01%
+45,160
New +$473K
MCY icon
3824
Mercury Insurance
MCY
$5.95B
$271K ﹤0.01%
5,411
-886
-14% -$47.5K
RLI icon
3825
RLI Corp
RLI
$5.91B
$271K ﹤0.01%
10,224
+2,952
+41% +$80K

Similar funds

Barclays's Q3 2015 Portfolio in Review

As of Q3 2015, Barclays held 7,503 positions worth $82.9B, down 6.9% from $89.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Barclays deployed $2.62B of net new capital in Q3 2015, opening 382 new positions and adding to 2,612 existing holdings. Its largest new stake was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,240,885 shares worth $1.3B.

By sector, the portfolio is most concentrated in Healthcare at 4.8% of assets, down from 6.6% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $830M trimmed.

  • Barclays's largest Q3 2015 buy was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,240,885 shares worth $1.3B.
  • Barclays added most to PRECISION CASTPARTS CORP in Q3 2015, an estimated $281M increase.
  • Barclays's biggest Q3 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $830M.
  • Barclays fully exited DIRECTV COM STK (DE) in Q3 2015, selling an estimated $126M.
  • Barclays's ten largest holdings make up 28% of its $82.9B portfolio in Q3 2015.
  • Barclays opened 382 new positions and closed 515 in Q3 2015.
  • Barclays's portfolio value fell 6.9% quarter-over-quarter to $82.9B.

Based on Barclays's 13F filing for Q3 2015, filed 13 Nov 2015.